Exosomes as a Tool for Disease Progression Monitoring in Humans and Animals
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 50705
Special Issue Editors
Interests: liquid biopsy; exosomes; phage display; peptides
Interests: B cell neoplasia; biomarkers; peptides
Special Issue Information
Dear Colleagues,
For years thought to be “unfunctional garbage bags”, exosomes are now considered as one of the most potentially applicable tools for monitoring several disease conditions, both in humans and in animals. Due to their endosomal origin, exosomes are released in the extracellular space by almost all cell types during different physiological conditions. Reflecting the genomic, proteomic, and lipidomic profile of their parental cells, circulating exosomes are potential biomarkers for the prediction of disease burden both at an early stage and in response to therapy, which could have a relevant impact on precision medicine.
In particular, in combination with liquid biopsy tests, exosomes together with their rich content of biomolecular components could allow the screening of individual patients for the presence of disease indicators using a simple blood test, thus providing an alternative approach to the costly, invasive, and sometimes “risky” traditional procedures.
This Special Issue will discuss recent advances in the field of exosomes as indicators of disease progression both in humans and in animals.
Dr. Enrico Iaccino
Dr. Selena Mimmi
Dr. Shibu Krishnan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liquid biopsy
- exosomes
- extracellular vesicles
- cancer biomarkers
- metastatic niche
- cardiovascular diseases
- neurological diseases
- veterinary diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.